Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from QuantumPharm, Inc. ( (HK:2228) ).
XtalPi Holdings Limited has successfully completed the placing of 285,920,000 new shares, representing approximately 6.64% of its enlarged issued share capital, at a price of HK$9.28 per share. The placing, which raised approximately HK$2,629.8 million in net proceeds, will primarily fund the company’s ongoing product iterations and upgrades, including advancements in its robotic laboratory technology and AI capabilities. These developments are expected to enhance XtalPi’s research and development technological capabilities, positioning the company to address key industry challenges and improve operational efficiency.
The most recent analyst rating on (HK:2228) stock is a Hold with a HK$10.50 price target. To see the full list of analyst forecasts on QuantumPharm, Inc. stock, see the HK:2228 Stock Forecast page.
More about QuantumPharm, Inc.
Average Trading Volume: 175,357,095
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$39.51B
For an in-depth examination of 2228 stock, go to TipRanks’ Overview page.